SecBot SecBot
8-K ·Filed Jun 8, 2026

VTAK

Catheter Precision, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed4mo ago SEC0001437749-26-019779
8-K Item 1.01 + 5.02 (likely routine officer/director compensation agreement)
Actionable Insight • Neutral

Monitor the closing conditions and subsequent registration statement filing by Volato. The freely tradeable flyExclusive shares received by VTAK provide a liquid asset that can be sold immediately, while the SOAR shares are restricted until registration. The transaction does not change VTAK's operational outlook but represents a $1,000,000 cash deployment into a strategic investment.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+20d ⚠ clustered
VTAK ▼ -24.88% at T+20d
NEUTRAL call -24.88% · α vs SPY -26.51% · entry $1.02 → $0.7662
Next anchor: T+60d due 8w ago
Entry = T+0 close
Jun 8, 2026
via day close
T+1d
-2.25%
call -2.25% · α -1.95%
$0.9971
settled 5mo ago
T+5d
+2.94%
call +2.94% · α +0.83%
$1.05
settled 5mo ago
T+20d
-24.88%
call -24.88% · α -26.51%
$0.7662
settled 4mo ago
T+60d
Pending
due 8w ago

Price Chart

Loading chart...

Executive Summary

Catheter Precision (VTAK) entered into a Securities Purchase Agreement to purchase 2,941,176 shares of Volato Group (SOAR) common stock at $0.34/share for $1,000,000 in a private placement. As consideration for VTAK's participation, Volato agreed to deliver 451,901 freely tradeable shares of flyExclusive, Inc. common stock to VTAK, valued at approximately $1,100,000 as of June 5, 2026. The transaction is structured as a strategic investment by VTAK in SOAR, with VTAK receiving additional compensation in the form of third-party equity securities.

Key Financial Metrics

Deal Value
$1.0M

Key Facts

  • VTAK agreed to purchase 2,941,176 shares of SOAR common stock at $0.34/share for an aggregate purchase price of $1,000,000.
  • As consideration for VTAK's participation, Volato agreed to deliver 451,901 freely tradeable shares of flyExclusive, Inc. common stock to VTAK, valued at approximately $1,100,000 as of June 5, 2026.
  • The closing is subject to customary conditions including accuracy of representations, performance of covenants, and absence of a Material Adverse Effect with respect to Volato.
  • VTAK received registration rights requiring Volato to file a resale registration statement on Form S-3 within 10 calendar days and use best efforts to have it declared effective.
  • The total aggregate offering under the Purchase Agreement is approximately $2,210,000 across all purchasers, with VTAK's subscription amount being $1,000,000.

Financial Impact

VTAK deployed $1,000,000 cash to acquire SOAR shares and received approximately $1,100,000 in freely tradeable flyExclusive shares as a participation incentive. Net cash outflow of $1,000,000 with a non-cash compensation asset of ~$1,100,000.

cashinvestmentsequity securities holdings

Risk Factors

  • The closing is subject to conditions including no Material Adverse Effect at Volato — if Volato's business deteriorates, the deal may not close.
  • The $1,000,000 cash outlay reduces VTAK's cash reserves for its own operations.
  • The value of the SOAR shares and flyExclusive shares received is subject to market volatility — there is no guarantee VTAK will realize the current market values through future sales.
  • Registration rights are subject to carve-outs for Excluded Registration Events which could delay resale of SOAR shares.

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001437749-26-019779
Exhibit: ex_973563.htm0001437749-26-019779
Document: vtak20260607_8k.htm0001437749-26-019779
Document: 0001437749-26-019779-index-headers.html0001437749-26-019779
Document: 0001437749-26-019779-index.html0001437749-26-019779
Document: 0001437749-26-019779.txt0001437749-26-019779
23 reports for VTAK
Performance horizon
67% Hit rate @ T+5 4 of 6 directional calls Went positive at some point 6 of 6 best @ T+60▲ +82.93%Jun 22, 2026
Filters
Rows
Reports for VTAK — sortable, filterable
TypeNow
Oct 9, 2026
18d ago
8-K
BEARISH ★ 7/10
$1.00 $0.8200▲ +18.00%▲ +16.51%$0.6500 (+35.00%)
Oct 5, 2026
22d ago
Press Release
NEUTRAL ★ 2/10
$1.62 $1.00▼ −38.27%▼ −38.69%$0.6500 (−59.88%)
Oct 2, 2026
25d ago
8-K
NEUTRAL ★ 5/10
$1.62 $1.00▼ −38.27%▼ −38.69%$0.6500 (−59.88%)
Oct 2, 2026
25d ago
Press Release
NEUTRAL ★ 4/10
$1.62 $1.00▼ −38.27%▼ −38.69%$0.6500 (−59.88%)
Sep 28, 2026
29d ago
Press Release
NEUTRAL ★ 2/10
$0.1467awaiting T+5—$0.6500 (+343.08%)
Sep 25, 2026
4w ago
8-K
NEUTRAL ★ 3/10
$0.1467awaiting T+5—$0.6500 (+343.08%)
Aug 27, 2026
8w ago
Press Release
NEUTRAL ★ 4/10
$0.2027 $0.1966▼ −3.01%▼ −3.28%$0.6500 (+220.67%)
Aug 11, 2026
11w ago
Press Release
NEUTRAL ★ 2/10
$0.2900 $0.2229▼ −23.14%▼ −22.73%$0.6500 (+124.14%)
Aug 4, 2026
12w ago
Press Release
NEUTRAL ★ 3/10
$0.2760 $0.2930▲ +6.16%▲ +6.26%$0.6500 (+135.51%)
Jul 13, 2026
15w ago
EFFECT
BEARISH ★ 7/10
$0.6504 $0.5020▲ +22.82%▲ +21.87%$0.6500 (+0.06%)
Showing 10 of 23

US Market Status

Market Closed — Opens in 6h 35m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 8, 2026